Vaccinex — Company Overview, News & Financial Data

Vaccinex (NASDAQ:VCNX) is a biotechnology company focused on the discovery and development of targeted biotherapeutics to treat serious diseases and conditions including cancer, neurodegenerative diseases, and autoimmune disorders. Leveraging its proprietary ActivMAb® platform, Vaccinex has been at the forefront of creating antibody therapies that can potentially transform patient care in these challenging areas. The company's flagship projects include pioneering treatments for Huntington’s disease and non-small cell lung cancer, with the objective of advancing these therapies through clinical trials to bring new hope to patients. At its core, Vaccinex is dedicated to harnessing the power of the immune system to fight disease and improve lives.